Cryochambers are used to induce a whole body cryotherapeutic response. According to the WHO nomenclature of medical devices, cryosurgical units for general purpose are covered under UMDNS code 11-067, 18-051.
Europe Cryochambers market is estimated to account for US$ 53.1 Mn in terms of value in 2019 and is expected to reach US$ 76.5 Mn by the end of 2027.
Europe Cryochambers Market: Drivers
Increasing number of cryotherapy establishments is expected to boost growth of Europe cryochambers market over the forecast period. For instance, Glass House Retreat, a purpose-built spa, detox and weight loss retreat in the U.K, houses a cryotherapy chamber.
Europe Cryochambers Market: Opportunities
Development of novel sensors to monitor the depth of frozen skin tissue is expected to offer a lucrative growth opportunities for players in the market. For instance, in February 2020, researchers at University of Ioannina, Greece, reported development of an optical fiber-array sensor to monitor the depth of frozen skin tissue during freezing–thawing cycles in cryosurgery.
Europe Cryochambers Market: Restraints
Adverse effects of cryotherapy are expected to hamper growth of Europe cryochambers market. Modern cryogenic chambers use mixture of 21% oxygen and 79% nitrogen to achieve and maintain the near-cryogenic temperatures in the system. However, this exposes patients to variety of risks and physiological hazards of evaporation of tissue water and oxygen deficiency. Exposure to sub-zero temperatures in cryochambers may lead to hypothermia, inert gas asphyxiation, frostbites (cold burn), numbness & irritation of the skin, nerve damage, eye injury from the extreme low temperatures or even death in rare cases.
Cryochambers segment in Europe Cryochambers market was valued at US$ 31.3 Mn in 2018 and is expected to reach US$ 49.4 Mn by 2027 at a CAGR of 5.4% during the forecast period. Increasing number of non-invasive and minimally-invasive procedures performed every year is expected to be the major driving force for the segment growth in the near future. Factors such as presence of established cryotherapy companies, presence of skilled professionals, and increasing awareness about the therapy is expected to support growth of the segment.
The Dermatology & Beauty Applications segment held dominant position in Europe cryochambers market in 2018, accounting for 46.7% share in terms of value, followed by Sports Medicine & Pain Management and Others, respectively. The demand for non-invasive and minimally invasive procedures is increasing exponentially owing to increasing consumer preference on enhancing one’s physically features, and treating skin problems. The incidence of both non-melanoma and melanoma skin cancers has been increasing over the past decades. According to the World Health Organization’s 2018 health statistics, around 2 to 3 million cases of non-melanoma skin cancers, and 132,000 melanoma skin cancers occur globally each year.
Cryotherapy can be effective during knee replacement surgery to maintain the surgical area at the desired temperature. Moreover, postoperative cryotherapy can aid in reducing pain, bleeding, length of stay, analgesic requirement and swelling after total knee arthroplasty.
Use of whole-body cryotherapy can aid reducing blood levels of asprosin in menopausal women. Moreover, cryotherapy does not significantly affect insulin concentration or insulin resistance.
Europe Cryochambers Market: Competitive Landscape
Major players in Europe cryochambers include, Zimmer MedizinSysteme GmbH, KrioSystem Sp. z.o.o, Air Products and Chemicals, Inc., CSA Medical, Inc., METRUM CRYOFLEX Sp. z o.o., Sp. K., Novotech S.R.O, CryoAction Limited, JUKA SP. Z.O.O. SP.K., Cryosense, and CRYO Science.
Europe Cryochambers Market: Key Developments
August 2019: BTG International Canada Inc., a part of BTG plc., a global specialist healthcare company, received a medical device license from Health Canada for the ICEfx Cryoablation System
January 2019: CRYO Science, in partnership with Canopy Environmental, announced that the U.S. Air Force's special tactical unit incorporated the CRYO Arctic Whole Body Cryotherapy Chamber into their squadron at Joint Base Lewis-McChord, Washington